Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Interim policy on the packaging, labelling and sale of naloxone kits December 9, 2024 On this page Background Helping to ensure the supply of naloxone kits Conditions for the packaging, labelling and sale of naloxone kits Background Naloxone kits play a critical role in the…
Notice: Interim policy on naloxone kits, and authorized re-administration time for naloxone products Naloxone is a life-saving medication that, when used quickly, temporarily reverses the effects of opioid overdoses. Naloxone is a critical life saving tool for healthcare…
Archived Cover Letter - Policy on Counterfeit Health Products (POL-0048) Health Products and Food Branch Inspectorate Graham Spry Building, 3rd Floor 250 Lanark Avenue Address Locator 2003D OTTAWA, Ontario K1A 0K9 May 14, 2010 10-110180-14 To: All Interested Parties I am pleased…
Archived Policy on Counterfeit Health Products (POL-0048) (PDF Version - 50 K) Contact Information Cover Letter Our Mandate: To promote good nutrition and informed use of drugs, food, medical devices and natural health products, and to maximize the safety and efficacy of drugs,…
Inspection tracker: Drug manufacturing establishments As part of Health Canada's ongoing commitment to openness and transparency, the Department is publishing information regarding emerging issues identified through our drug inspection program. This tracker provides a snapshot of…
Inspectorate Program: Annual Inspection Summary Report 2012-2013 Contact Information The Annual Inspection Summary Report outlines inspection activities conducted by Health Canada's Inspectorate Program for the fiscal year 2012-2013. Highlights of the report: Results and…
Inspectorate Program Annual Inspection Summary Report 2013-2014 (PDF Version - 2,607 K) Contact Information Table of Contents Our Vision Our Mission Message from the Directors General Executive Summary Chapter 1 Blood Inspection Program Chapter 2 Cells, Tissues and Organs (CTO)…
Inspectorate Program - Annual Inspection Summary Report 2014-2015 (PDF Version - 1.84 M) Our Vision To be a trusted national organization committed to regulatory compliance and enforcement activities of health products based on modern risk management decision-making strategies…
Inspectorate Program Annual Inspection Summary Report 2015 – 2016 (PDF format, 2.36 MB, 49 pages) Table of Contents Message from the Assistant Deputy Minister Executive Summary Key priorities Transparency Risk-based inspection approach Foreign inspection approach Data integrity…
Reports Inspectorate Program Annual Inspection Summary Report 2013-2014 Summary Report of Inspections of Clinical Trials Conducted from April 2004 to March 2011 [2012-03-28] Summary Report of the Inspections of Clinical Trials Conducted in 2003 / 2004 Summary Report of the…
Page 4182 sur 6399Affichage de 41811 à 41820 sur 63986
Version préliminaire : la couverture est limitée au corpus actuel et les fonctionnalités peuvent changer.
